Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing.

Abstract excerpt

We provide an up-to-date and accurate minimum point prevalence of genetically defined skeletal muscle channelopathies which is important for understanding the population impact, planning for treatment needs and future clinical trials. Skeletal muscle channelopathies include myotonia congenita (MC), sodium channel myotonia (SCM), paramyotonia congenita (PMC), hyperkalemic periodic paralysis (hyperPP), hypokalemic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Andersen Syndrome
• Share to Channelopathies